Evaluation of the Merlin, Micronaut system for automated antimicrobial susceptibility testing of Pseudomonas aeruginosa and Burkholderia species isolated from cystic fibrosis patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 8, 2003, Pages 496-500

  Haussler S ^a   Ziesing, S ^a   Rademacher, G ^a   Hoy, L ^a   Weissbrodt H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BURKHOLDERIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DILUTION; HUMAN; IN VITRO STUDY; INCUBATION TIME; INTERMETHOD COMPARISON; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REPRODUCIBILITY;

ANTI-BACTERIAL AGENTS; AUTOMATION; BACTERIOLOGICAL TECHNIQUES; BURKHOLDERIA; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SENSITIVITY AND SPECIFICITY;

EID: 0041909720     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0974-7     Document Type: Article

References (12)

1. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194-222
2. Morlin GL, Hedges DL, Smith AL, Burns JL (1994) Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa. J Clin Microbiol 32:1027-1030
3. Saiman L, Mehar F, Niu WW, Neu HC, Shaw KJ, Miller G, Prince A (1996) Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 23:532-537
4. Saiman L, Burns JL, Whittier S, Krzewinski J, Marshall SA, Jones RN (1999) Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis. J Clin Microbiol 37:2987-2991
5. Thomassen MJ, Demko CA, Boxerbaum B, Stern RC, Kuchenbrod PJ (1979) Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis 140:873-880
6. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539-574
7. Haussler S, Tummler B, Weissbrodt H, Rohde M, Steinmetz I (1999) Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis 29:621-625
8. Haussler S, Lehmann C, Berslege C, Rohde M, Claßen M, Tümmler B, Vandamme P, Steinmetz I (2003) Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur J Clin Microbiol Infect Dis 22:249-253
9. National Committee of Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. NCCLS document M100-S12. NCCLS, Wayne, PA
10. Burns JL, Saiman L, Whittier S, Larone D, Krzewinski J, Liu Z, Marshall SA, Jones RN (2000) Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 38:1818-1822
11. Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, Givskov M, Parsek MR (2001) Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol 183:5395-5401
12. Burns JL, Saiman L, Whittier S, Krzewinski J, Liu Z, Larone D, Marshall SA, Jones RN (2001) Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn Microbiol Infect Dis 39:257-260